Skip to main content
/
Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
6.53
+0.73 (12.59%)
At close: May 2, 2025

Revenue by Product

Fiscal year is April - March.
Fiscal Year
 FY 2023FY 2022FY 2021FY 2020FY 2019 2016 - 2018
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Pharmaceutical
314.56B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
-38.41%
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
 FY 2023FY 2022FY 2021FY 2020FY 2019 2016 - 2018
Period Ending
 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
North America
159.04B
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-51.58%
Log In
Log In
Log In
Log In
Upgrade
Japan
114.66B
Log In
Log In
Log In
Log In
Upgrade
Japan Growth
-9.08%
Log In
Log In
Log In
Log In
Upgrade
Asia
40.86B
Log In
Log In
Log In
Log In
Upgrade
Global
-
Log In
Log In
Log In
Log In
Upgrade
Global Growth
-
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade
China Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Overseas
-
Log In
Log In
Log In
Log In
Upgrade
Other Overseas Growth
-
Log In
Log In
Log In
Log In
Upgrade